DZ2892A1 - Livraison d'agent actif atomisé par modulation résistance de débit. - Google Patents

Livraison d'agent actif atomisé par modulation résistance de débit.

Info

Publication number: DZ2892A1
Authority: DZ; Algeria
Prior art keywords: delivery; active agent; flow resistance; resistance modulation; atomized active
Prior art date: 1998-09-14

Application number

DZ990192A

Other languages

English (en)

Inventor

Andrew Clark

Original Assignee

Inhale Therapeutic Syst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-14

Filing date

1999-09-13

Publication date

2003-12-15

1999-09-13 Application filed by Inhale Therapeutic Syst filed Critical Inhale Therapeutic Syst

2003-12-15 Application granted granted Critical

2003-12-15 Publication of DZ2892A1 publication Critical patent/DZ2892A1/fr

Links

239000013543 active substance Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Otolaryngology (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)

DZ990192A 1998-09-14 1999-09-13 Livraison d'agent actif atomisé par modulation résistance de débit. DZ2892A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10016398P	1998-09-14	1998-09-14

Publications (1)

Publication Number	Publication Date
DZ2892A1 true DZ2892A1 (fr)	2003-12-15

Family

ID=22278404

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ990192A DZ2892A1 (fr)	1998-09-14	1999-09-13	Livraison d'agent actif atomisé par modulation résistance de débit.

Country Status (44)

Country	Link
EP (1)	EP1117442A1 (fr)
JP (1)	JP2002524535A (fr)
KR (1)	KR20010075063A (fr)
CN (1)	CN1317977A (fr)
AP (1)	AP1374A (fr)
AR (1)	AR022090A1 (fr)
AU (1)	AU753014B2 (fr)
BG (1)	BG105430A (fr)
BR (1)	BR9913722A (fr)
CA (1)	CA2343920A1 (fr)
CO (1)	CO5130023A1 (fr)
CZ (1)	CZ2001829A3 (fr)
DZ (1)	DZ2892A1 (fr)
EA (1)	EA003476B1 (fr)
EE (1)	EE200100151A (fr)
GE (1)	GEP20043257B (fr)
GT (1)	GT199900156A (fr)
HK (1)	HK1042231A1 (fr)
HN (1)	HN1999000159A (fr)
HR (1)	HRP20010189A2 (fr)
HU (1)	HUP0103837A3 (fr)
ID (1)	ID28845A (fr)
IL (2)	IL141562A0 (fr)
IS (1)	IS5878A (fr)
LT (1)	LT4897B (fr)
LV (1)	LV12658B (fr)
MA (1)	MA25590A1 (fr)
MY (1)	MY129282A (fr)
NO (1)	NO20011251L (fr)
NZ (1)	NZ510168A (fr)
OA (1)	OA11781A (fr)
PA (1)	PA8481901A1 (fr)
PE (1)	PE20001061A1 (fr)
PL (1)	PL195574B1 (fr)
SA (1)	SA99200718B1 (fr)
SK (1)	SK3442001A3 (fr)
TN (1)	TNSN99173A1 (fr)
TR (1)	TR200101182T2 (fr)
TW (1)	TWI226248B (fr)
UA (1)	UA76085C2 (fr)
UY (1)	UY25711A1 (fr)
WO (1)	WO2000015262A1 (fr)
YU (1)	YU24201A (fr)
ZA (1)	ZA200101995B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6956021B1 (en)	1998-08-25	2005-10-18	Advanced Inhalation Research, Inc.	Stable spray-dried protein formulations
HK1049621A1 (zh)	1999-06-09	2003-05-23	罗伯特‧E‧希弗斯	超临界流体辅助的喷雾和鼓泡乾燥
US6475468B2 (en) *	2001-02-15	2002-11-05	Aeropharm Technology Incorporated	Modulated release particles for aerosol delivery
CA2446904A1 (fr) *	2001-05-24	2003-04-03	Alexza Pharmaceuticals, Inc.	Administration d'esters medicamenteux par inhalation
EG24184A (en) *	2001-06-15	2008-10-08	Otsuka Pharma Co Ltd	Dry powder inhalation system for transpulmonary
CA2465675C (fr)	2001-11-20	2008-06-10	Advanced Inhalation Research, Inc.	Compositions particulaires ameliorees destinees a etre administrees par voie pulmonaire
US7759506B2 (en)	2002-02-25	2010-07-20	Diffusion Pharmaceuticals Llc	Bipolar trans carotenoid salts and their uses
WO2003072734A2 (fr)	2002-02-25	2003-09-04	Diffusion Pharmaceuticals Llc	Sels carotenoides trans bipolaires et leurs utilisations
CA2491129A1 (fr) *	2002-07-03	2004-01-15	Brigham And Women's Hospital, Inc.	Introduction par les voies aeriennes centrales pour l'administration systemique d'agents therapeutiques
JP2006513238A (ja) *	2002-12-19	2006-04-20	ファルマシア・コーポレーション	吸湿性薬物を含む非‐吸湿性製剤
DE10338403A1 (de) *	2003-08-18	2005-03-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum
GB0327723D0 (en) *	2003-09-15	2003-12-31	Vectura Ltd	Pharmaceutical compositions
US20070020299A1 (en)	2003-12-31	2007-01-25	Pipkin James D	Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
BRPI0510119A (pt)	2004-04-23	2007-09-25	Cydex Inc	formulação para dpi contendo sulfoaquil éter de ciclodextrina
UA95903C2 (ru) *	2005-02-24	2011-09-26	Дифьюжен Фармасьютикалз Ллк	Транс-каротиноиды, их синтез, лекарственная форма и применение
KR20070110418A (ko) *	2005-03-09	2007-11-16	오노 야꾸힝 고교 가부시키가이샤	입자 및 그 입자를 함유하는 제제
SI2952197T1 (sl)	2005-10-26	2017-09-29	Cydex Pharmaceuticals, Inc.	Sestavki sulfoalkil eter ciklodekstrina in metode priprave le-tega
US20100269819A1 (en) *	2006-08-14	2010-10-28	Sievers Robert E	Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions
CN101541311B (zh) *	2006-10-25	2013-01-23	大日本住友制药株式会社	不易结块的颗粒制剂
EP1925295A1 (fr) *	2006-11-22	2008-05-28	Boehringer Ingelheim Pharma GmbH & Co. KG	Formule de poudre stable contenant un nouveau anticholinergique
EP3483140A1 (fr)	2007-04-13	2019-05-15	Diffusion Pharmaceuticals LLC	Utilisation de transcaroténoïdes bipolaires en tant que prétraitement et dans le traitement d'une maladie vasculaire périphérique
US12370352B2 (en)	2007-06-28	2025-07-29	Cydex Pharmaceuticals, Inc.	Nasal and ophthalmic delivery of aqueous corticosteroid solutions
EA201070544A1 (ru)	2007-10-31	2010-12-30	Диффьюжн Фармасьютикалз Ллс	Новый класс терапевтических веществ, усиливающих диффузию низкомолекулярных соединений
ES2661215T3 (es) *	2009-05-20	2018-03-28	Aeras	Composiciones víricas; inmunógenas; secadas por pulverización; estables
KR101875843B1 (ko)	2009-06-22	2018-07-06	디퓨젼 파마슈티컬즈 엘엘씨	확산 촉진 화합물 및 그 화합물 단독 또는 혈전 용해제와 합쳐진 화합물의 용도
CN105287473A (zh)	2010-06-02	2016-02-03	扩散药品有限公司	包含双极性反式类胡萝卜素的组合物及其应用
SG11201406208QA (en)	2012-05-03	2014-11-27	Janssen Sciences Ireland Uc	Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
BR112015010601B1 (pt) *	2012-11-09	2022-07-19	Civitas Therapeutics, Inc.	Composição farmacêutica e uso da composição
US20180043585A9 (en) *	2013-09-20	2018-02-15	Virginia Commonwealth University	Delivery of particles using hygroscopic excipients
AU2015338717B2 (en)	2014-10-31	2018-12-20	Glaxosmithkline Intellectual Property Development Limited	Powder formulation
WO2017165667A1 (fr)	2016-03-24	2017-09-28	Diffusion Pharmaceuticals Llc	Utilisation de caroténoïdes trans bipolaires avec une chimiothérapie et une radiothérapie en vue du traitement d'un cancer
US20220378727A1 (en) *	2021-05-14	2022-12-01	The University Of Hong Kong	Dry powder formulations of tamibarotene for pulmonary and intranasal delivery
EP4493276A4 (fr) *	2022-03-18	2025-03-05	Pulmocures Ilac Egitim Danismanlik A.S.	Formes posologiques de substances actives utilisées contre des maladies virales dans un dispositif inhalateur de poudre sèche pour des symptômes provoqués par la covid-19 et d'autres maladies pulmonaires virales

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3155573A (en) *	1958-05-06	1964-11-03	Benger Lab Ltd	Inhalant composition and method of making same
EP0611567B1 (fr) *	1992-06-12	2002-08-28	Teijin Limited	Poudre ultra-fine pour inhalation et production de cette poudre
US6524557B1 (en) *	1994-12-22	2003-02-25	Astrazeneca Ab	Aerosol formulations of peptides and proteins
US5874064A (en)	1996-05-24	1999-02-23	Massachusetts Institute Of Technology	Aerodynamically light particles for pulmonary drug delivery
DE69732306T2 (de) *	1997-01-16	2006-01-12	Massachusetts Institute Of Technology, Cambridge	Zubereitung von partikelhaltigen arzneimitteln zur inhalation
US6086376A (en) *	1998-01-30	2000-07-11	Rtp Pharma Inc.	Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

1999
- 1999-09-09 MA MA25762A patent/MA25590A1/fr unknown
- 1999-09-13 CN CN99810871A patent/CN1317977A/zh active Pending
- 1999-09-13 NZ NZ510168A patent/NZ510168A/en unknown
- 1999-09-13 SK SK344-2001A patent/SK3442001A3/sk unknown
- 1999-09-13 DZ DZ990192A patent/DZ2892A1/fr active
- 1999-09-13 JP JP2000569846A patent/JP2002524535A/ja not_active Withdrawn
- 1999-09-13 EP EP99969035A patent/EP1117442A1/fr not_active Withdrawn
- 1999-09-13 TW TW088115876A patent/TWI226248B/zh not_active IP Right Cessation
- 1999-09-13 YU YU24201A patent/YU24201A/sh unknown
- 1999-09-13 PL PL99346768A patent/PL195574B1/pl not_active IP Right Cessation
- 1999-09-13 GE GEAP19995857A patent/GEP20043257B/en unknown
- 1999-09-13 AP APAP/P/2001/002093A patent/AP1374A/en active
- 1999-09-13 CZ CZ2001829A patent/CZ2001829A3/cs unknown
- 1999-09-13 ID IDW20010582A patent/ID28845A/id unknown
- 1999-09-13 PE PE1999000925A patent/PE20001061A1/es not_active Application Discontinuation
- 1999-09-13 HU HU0103837A patent/HUP0103837A3/hu unknown
- 1999-09-13 BR BR9913722-4A patent/BR9913722A/pt not_active IP Right Cessation
- 1999-09-13 HN HN1999000159A patent/HN1999000159A/es unknown
- 1999-09-13 IL IL14156299A patent/IL141562A0/xx not_active IP Right Cessation
- 1999-09-13 KR KR1020017003208A patent/KR20010075063A/ko not_active Ceased
- 1999-09-13 UA UA2001031707A patent/UA76085C2/uk unknown
- 1999-09-13 HR HR20010189A patent/HRP20010189A2/hr not_active Application Discontinuation
- 1999-09-13 AU AU60397/99A patent/AU753014B2/en not_active Ceased
- 1999-09-13 MY MYPI99003947A patent/MY129282A/en unknown
- 1999-09-13 EA EA200100300A patent/EA003476B1/ru active IP Right Revival
- 1999-09-13 AR ARP990104587A patent/AR022090A1/es unknown
- 1999-09-13 TR TR2001/01182T patent/TR200101182T2/xx unknown
- 1999-09-13 WO PCT/US1999/021109 patent/WO2000015262A1/fr not_active Ceased
- 1999-09-13 ZA ZA200101995A patent/ZA200101995B/en unknown
- 1999-09-13 HK HK02101738.3A patent/HK1042231A1/zh unknown
- 1999-09-13 OA OA1200100063A patent/OA11781A/en unknown
- 1999-09-13 EE EEP200100151A patent/EE200100151A/xx unknown
- 1999-09-13 CA CA002343920A patent/CA2343920A1/fr not_active Abandoned
- 1999-09-14 UY UY25711A patent/UY25711A1/es not_active Application Discontinuation
- 1999-09-14 CO CO99058265A patent/CO5130023A1/es unknown
- 1999-09-14 PA PA19998481901A patent/PA8481901A1/es unknown
- 1999-09-14 TN TNTNSN99173A patent/TNSN99173A1/fr unknown
- 1999-09-14 GT GT199900156A patent/GT199900156A/es unknown
- 1999-10-31 SA SA99200718A patent/SA99200718B1/ar unknown
2001
- 2001-02-21 IL IL141562A patent/IL141562A/en unknown
- 2001-03-05 IS IS5878A patent/IS5878A/is unknown
- 2001-03-13 NO NO20011251A patent/NO20011251L/no not_active Application Discontinuation
- 2001-03-14 LT LT2001021A patent/LT4897B/lt not_active IP Right Cessation
- 2001-03-14 LV LV010041A patent/LV12658B/xx unknown
- 2001-04-10 BG BG105430A patent/BG105430A/xx unknown

Also Published As

Publication number	Publication date
JP2002524535A (ja)	2002-08-06
MA25590A1 (fr)	2002-12-31
WO2000015262A1 (fr)	2000-03-23
YU24201A (sh)	2003-08-29
PE20001061A1 (es)	2000-10-08
MY129282A (en)	2007-03-30
IL141562A (en)	2007-07-24
CA2343920A1 (fr)	2000-03-23
CN1317977A (zh)	2001-10-17
ID28845A (id)	2001-07-05
HRP20010189A2 (en)	2005-04-30
CZ2001829A3 (cs)	2001-09-12
CO5130023A1 (es)	2002-02-27
PL195574B1 (pl)	2007-10-31
LT4897B (lt)	2002-02-25
PA8481901A1 (es)	2002-04-25
LT2001021A (en)	2001-11-26
OA11781A (en)	2005-07-26
BG105430A (en)	2001-12-29
HUP0103837A2 (hu)	2002-05-29
AP1374A (en)	2005-02-28
HK1042231A1 (zh)	2002-08-09
NZ510168A (en)	2003-09-26
ZA200101995B (en)	2002-03-11
AU753014B2 (en)	2002-10-03
TNSN99173A1 (fr)	2005-11-10
EE200100151A (et)	2002-06-17
LV12658B (lv)	2001-09-20
LV12658A (lv)	2001-05-20
EP1117442A1 (fr)	2001-07-25
UA76085C2 (en)	2006-07-17
GT199900156A (es)	2001-03-07
SA99200718B1 (ar)	2006-11-04
PL346768A1 (en)	2002-02-25
GEP20043257B (en)	2004-06-25
AP2001002093A0 (en)	2001-03-31
TWI226248B (en)	2005-01-11
UY25711A1 (es)	1999-11-17
NO20011251L (no)	2001-04-17
AR022090A1 (es)	2002-09-04
TR200101182T2 (tr)	2001-09-21
HUP0103837A3 (en)	2002-11-28
IL141562A0 (en)	2002-03-10
NO20011251D0 (no)	2001-03-13
IS5878A (is)	2001-03-05
EA003476B1 (ru)	2003-06-26
HN1999000159A (es)	1999-11-11
BR9913722A (pt)	2001-05-29
KR20010075063A (ko)	2001-08-09
EA200100300A1 (ru)	2001-10-22
AU6039799A (en)	2000-04-03
SK3442001A3 (en)	2001-11-06

Publication	Publication Date	Title
DZ2906A1 (fr)	2004-12-28	Livraison d'agent actif atomisé par modulation résistance de débit.
DZ2744A1 (fr)	2004-12-28	Distribution d'un agent actif aérosolé.
ID22349A (id)	1999-09-30	Turunan dari 8-azabisiklo [3.2.1] oktana-, 8-azabisiklo [3.2.1] okt-6-ena-, 9-azabisiklo-[3.3.1] nonana-, 9-aza-3-oksabisiklo [3.3.1] nonana- dan 9-aza-3-tiobisiklo [3.3.1] nonana, pembuatannya dan penggunaannya sebagai insektisida
BR9804500B1 (pt)	2010-06-15	derivado de amida, referida composição farmacêutica e agente terapêutico.
IL208330A0 (en)	2010-12-30	3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors ('statin drugs') and lisinopril, formulations comprising them and their use in the manufacture of medicaments and as medicaments for improving nerve conduction velocity or nerve blood flow in a non-human animal having diabetic neuropathy and for treating diabetic neuropathy in a non-human animal
DK1062217T3 (da)	2003-10-27	Herbicidt aktive 3-hydroxy-4-aryl-5-oxopyrazolinderivater
FI970788L (fi)	1997-02-25	Kasveilla käytettäviksi tarkoitettuja suihkutettavissa olevia, kalvon muodostavia järjestelmiä vaikuttavien aineiden antamiseksi
BR9913699A (pt)	2001-06-05	Composição inseticida
FR2791043B3 (fr)	2001-02-23	Pulverisateur d'assaisonnement
BR9904075A (pt)	2000-09-19	Cetonas
ITMI20001848A0 (it)	2000-08-08	Faramaci per l'incontinenza.
AU1389702A (en)	2002-04-02	Optically active 2,5-bisaryl-delta<sup>1</sup>-pyrrolines and their use as pest control agents
IT1307264B1 (it)	2001-10-30	Composizioni insetticide.
DE69504824D1 (de)	1998-10-22	Substituierte 5,6- dihydro-5-oxo-1,4 -dithiino-(2,3-d) pyridazin-dicarbonitrile, diese enthaltende zusammensetzungen und ihre verwendung als antimikrobielle mittel
DZ2597A1 (fr)	2003-03-01	Dérivés d'urée.
DE69301716D1 (de)	1996-04-11	3-azabicyclo(3.1.0) hexan-2-on Derivate, und diese als Herbizid wirksame Bestandteile enthaltende Herbizide Zusammensetzungen
IT1312355B1 (it)	2002-04-15	Composti pirrolici aventi elevata attivita' erbicida e loro utilizzoagronomico
IT237913Y1 (it)	2000-09-29	Valvola per lo scarico d'aria,perfezionata
FR2782243B1 (fr)	2001-08-17	Preparation d'une composition phytosanitaire solide par atomisation en presence d'un agent anti-mousse
ES1040172Y (es)	1999-07-01	Nuevo distribuidor por bola de sustancias ceroseas.
DE59904440D1 (de)	2003-04-10	Gezogene Landwirtschaftliche Feldspritze
UA43435C2 (uk)	2001-12-17	Композиція інгредієнтів для гіркої настоянки "старовинна"
IT1298987B1 (it)	2000-02-07	Composizioni terapeutiche ad attivita' antivirale comprendenti yohimbina e/o suoi sali come principio attivo
ZA99866B (en)	2000-08-04	2-(pyrazolyloxy)pyridin-3-ylacetic acid derivatives, compositions comprising them and their use for controlling harmful fungi and animal pests.
ES1040127Y (es)	1999-07-01	Valvula dosificadora perfeccionada.